Angiosyn is Biotechnology in United States that focus on initial therapeutic indication business. Founded in 2003. They cover business area such as operator, novel proprietary biologic, angiogenesis, ophthalmic disease, macular degeneration, diabetic retinopathy, decrease vision, blindness.
2003
( 23 years old in 2026 )
Initial Therapeutic Indication
-
3333 North Torrey Pines Court
Suite 150, La Jolla
San Diego, CA 92037
United States
Private
operatornovel proprietary biologicangiogenesisophthalmic diseasemacular degenerationdiabetic retinopathydecrease visionblindness
* We use standard office opening hours in near Angiosyn's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Angiosyn is Biotechnology business from United States that founded in 2003 (23 years old in 2026), Angiosyn business is focusing on Initial Therapeutic Indication.
Angiosyn headquarter office and corporate office address is located in 3333 North Torrey Pines Court Suite 150, La Jolla San Diego, CA 92037 United States.
Angiosyn was founded in United States.
In 2026, Angiosyn is currently focus on initial therapeutic indication sector.
Above is snippet of Google Trends for "initial therapeutic indication" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Angiosyn, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
